122 related articles for article (PubMed ID: 16762635)
1. Targeted disruption of FANCC and FANCG in human cancer provides a preclinical model for specific therapeutic options.
Gallmeier E; Calhoun ES; Rago C; Brody JR; Cunningham SC; Hucl T; Gorospe M; Kohli M; Lengauer C; Kern SE
Gastroenterology; 2006 Jun; 130(7):2145-54. PubMed ID: 16762635
[TBL] [Abstract][Full Text] [Related]
2. Disruption of the FA/BRCA pathway in bladder cancer.
Neveling K; Kalb R; Florl AR; Herterich S; Friedl R; Hoehn H; Hader C; Hartmann FH; Nanda I; Steinlein C; Schmid M; Tonnies H; Hurst CD; Knowles MA; Hanenberg H; Schulz WA; Schindler D
Cytogenet Genome Res; 2007; 118(2-4):166-76. PubMed ID: 18000367
[TBL] [Abstract][Full Text] [Related]
3. Investigation of Fanconi anemia protein interactions by yeast two-hybrid analysis.
Huber PA; Medhurst AL; Youssoufian H; Mathew CG
Biochem Biophys Res Commun; 2000 Feb; 268(1):73-7. PubMed ID: 10652215
[TBL] [Abstract][Full Text] [Related]
4. In vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumor.
van der Heijden MS; Brody JR; Dezentje DA; Gallmeier E; Cunningham SC; Swartz MJ; DeMarzo AM; Offerhaus GJ; Isacoff WH; Hruban RH; Kern SE
Clin Cancer Res; 2005 Oct; 11(20):7508-15. PubMed ID: 16243825
[TBL] [Abstract][Full Text] [Related]
5. Gene-specific selection against experimental fanconi anemia gene inactivation in human cancer.
Gallmeier E; Hucl T; Calhoun ES; Cunningham SC; Bunz F; Brody JR; Kern SE
Cancer Biol Ther; 2007 May; 6(5):654-60. PubMed ID: 17387268
[TBL] [Abstract][Full Text] [Related]
6. Fanconi anemia pathway heterogeneity revealed by cisplatin and oxaliplatin treatments.
Kachnic LA; Li L; Fournier L; Willers H
Cancer Lett; 2010 Jun; 292(1):73-9. PubMed ID: 20034732
[TBL] [Abstract][Full Text] [Related]
7. Chemosensitizing tumor cells by targeting the Fanconi anemia pathway with an adenovirus overexpressing dominant-negative FANCA.
Ferrer M; de Winter JP; Mastenbroek DC; Curiel DT; Gerritsen WR; Giaccone G; Kruyt FA
Cancer Gene Ther; 2004 Aug; 11(8):539-46. PubMed ID: 15192709
[TBL] [Abstract][Full Text] [Related]
8. Four human FANCG polymorphic variants show normal biological function in hamster CHO cells.
Hinz JM; Nham PB; Yamada NA; Tebbs RS; Salazar EP; Hinz AK; Mohrenweiser HW; Jones IM; Thompson LH
Mutat Res; 2006 Dec; 602(1-2):34-42. PubMed ID: 17010390
[TBL] [Abstract][Full Text] [Related]
9. FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3.
Wilson JB; Yamamoto K; Marriott AS; Hussain S; Sung P; Hoatlin ME; Mathew CG; Takata M; Thompson LH; Kupfer GM; Jones NJ
Oncogene; 2008 Jun; 27(26):3641-52. PubMed ID: 18212739
[TBL] [Abstract][Full Text] [Related]
10. Tetratricopeptide-motif-mediated interaction of FANCG with recombination proteins XRCC3 and BRCA2.
Hussain S; Wilson JB; Blom E; Thompson LH; Sung P; Gordon SM; Kupfer GM; Joenje H; Mathew CG; Jones NJ
DNA Repair (Amst); 2006 May; 5(5):629-40. PubMed ID: 16621732
[TBL] [Abstract][Full Text] [Related]
11. Functional defects in the fanconi anemia pathway in pancreatic cancer cells.
van der Heijden MS; Brody JR; Gallmeier E; Cunningham SC; Dezentje DA; Shen D; Hruban RH; Kern SE
Am J Pathol; 2004 Aug; 165(2):651-7. PubMed ID: 15277238
[TBL] [Abstract][Full Text] [Related]
12. Genetic inactivation of the Fanconi anemia gene FANCC identified in the hepatocellular carcinoma cell line HuH-7 confers sensitivity towards DNA-interstrand crosslinking agents.
Palagyi A; Neveling K; Plinninger U; Ziesch A; Targosz BS; Denk GU; Ochs S; Rizzani A; Meier D; Thasler WE; Hanenberg H; De Toni EN; Bassermann F; Schäfer C; Göke B; Schindler D; Gallmeier E
Mol Cancer; 2010 May; 9():127. PubMed ID: 20509860
[TBL] [Abstract][Full Text] [Related]
13. In silico study of missense variants of FANCA, FANCC and FANCG genes reveals high risk deleterious alleles predisposing to Fanconi anemia pathogenesis.
Shahid M; Azfaralariff A; Zubair M; Abdulkareem Najm A; Khalili N; Law D; Firasat S; Fazry S
Gene; 2022 Feb; 812():146104. PubMed ID: 34864095
[TBL] [Abstract][Full Text] [Related]
14. Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated.
Kennedy RD; Chen CC; Stuckert P; Archila EM; De la Vega MA; Moreau LA; Shimamura A; D'Andrea AD
J Clin Invest; 2007 May; 117(5):1440-9. PubMed ID: 17431503
[TBL] [Abstract][Full Text] [Related]
15. Germ line Fanconi anemia complementation group C mutations and pancreatic cancer.
Couch FJ; Johnson MR; Rabe K; Boardman L; McWilliams R; de Andrade M; Petersen G
Cancer Res; 2005 Jan; 65(2):383-6. PubMed ID: 15695377
[TBL] [Abstract][Full Text] [Related]
16. Spectrum of sequence variation in the FANCG gene: an International Fanconi Anemia Registry (IFAR) study.
Auerbach AD; Greenbaum J; Pujara K; Batish SD; Bitencourt MA; Kokemohr I; Schneider H; Lobitzc S; Pasquini R; Giampietro PF; Hanenberg H; Levran O;
Hum Mutat; 2003 Feb; 21(2):158-68. PubMed ID: 12552564
[TBL] [Abstract][Full Text] [Related]
17. Genomic instability in mice is greater in Fanconi anemia caused by deficiency of Fancd2 than Fancg.
Reliene R; Yamamoto ML; Rao PN; Schiestl RH
Cancer Res; 2010 Dec; 70(23):9703-10. PubMed ID: 21118969
[TBL] [Abstract][Full Text] [Related]
18. Role of the Fancg gene in protecting cells from particulate chromate-induced chromosome instability.
Savery LC; Grlickova-Duzevik E; Wise SS; Thompson WD; Hinz JM; Thompson LH; Wise JP
Mutat Res; 2007 Jan; 626(1-2):120-7. PubMed ID: 17097336
[TBL] [Abstract][Full Text] [Related]
19. Targeted disruption of the murine Fanconi anemia gene, Fancg/Xrcc9.
Yang Y; Kuang Y; Montes De Oca R; Hays T; Moreau L; Lu N; Seed B; D'Andrea AD
Blood; 2001 Dec; 98(12):3435-40. PubMed ID: 11719385
[TBL] [Abstract][Full Text] [Related]
20. Genetic disruption of both Fancc and Fancg in mice recapitulates the hematopoietic manifestations of Fanconi anemia.
Pulliam-Leath AC; Ciccone SL; Nalepa G; Li X; Si Y; Miravalle L; Smith D; Yuan J; Li J; Anur P; Orazi A; Vance GH; Yang FC; Hanenberg H; Bagby GC; Clapp DW
Blood; 2010 Oct; 116(16):2915-20. PubMed ID: 20606166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
